<!doctype html>
<html>
<head>
<title>Cheyenne</title>
<!--[if IE]>
<meta http-equiv="X-UA-Compatible" content="IE=Edge,chrome=1"/>
<![endif]-->
<meta charset="utf-8"/>
<meta name="application-name" content="FileMan Schema"/>
<meta name="fragment" content="!">
<link rel='stylesheet' href='fmBase.css' type='text/css'>
</head>
<body>
<div id="header">
<h1 id="logo"><a href="index.html">Cheyenne Schema Browser</a></h1>
</div>
<div id="fmql">
<div class="fmqlResults"><div id="resultsHeader"><h1><a href='index.html'>Files</a> > SUBSEQUENT COURSE OF TREATMENT</h1></div><div id="results"><dl><dt>parent</dt><dd><a href="165_5.html">165.5</a></dd><dt>name</dt><dd>SUBSEQUENT COURSE OF TREATMENT</dd><dt>number</dt><dd>165.51</dd><dt>Fields</dt><dd><table><thead><tr><th>#</th><th>Name</th><th>Location</th><th>Type</th><th>Details</th><th>Index</th><th>Description</th></tr></thead><tbody><tr><td>.01</td><td>initiation date</td><td>0;1</td><td>DATE-TIME</td><td></td><td></td><td>Record the date that subsequent therapy was initiated.</td></tr><tr><td>.02</td><td>hema trans/endocrine proc</td><td>0;18</td><td>POINTER</td><td><a href="167.html">167</a></td><td></td><td>Identifies systemic therapeutic procedures administered as partof subsequent course of treatment at this and all other facilities.If none of these procedures were administered, then this itemrecords the reason they were not performed.  These include bonemarrow transplants, stem cell harvests, surgical and/or radiationendocrine therapy.For further information see FORDS pages 182-183.</td></tr><tr><td>.021</td><td>hema trans/endocrine proc date</td><td>0;19</td><td>DATE-TIME</td><td></td><td></td><td>Records the date on which hematologic transplantand endocrine procedures were performed.</td></tr><tr><td>.03</td><td>radiation therapy to cns</td><td>0;10</td><td>SET OF CODES</td><td>0:None<br/>1:Radiation Given<br/>7:Refused Radiation<br/>8:Recommended, Unknown if Given<br/>9:Unknown if Recommended/Given or Not Applicable<br/></td><td></td><td>This is a code indicating whether radiation therapy was performed tothe brain and/or central nervous system.</td></tr><tr><td>.031</td><td>radiation therapy to cns date</td><td>0;17</td><td>DATE-TIME</td><td></td><td></td><td>This is the date on which brain/CNS radiation therapy was initiated.</td></tr><tr><td>.04</td><td>surgery of primary site</td><td>0;4</td><td>NUMERIC</td><td></td><td></td><td>Records the surgical procedure(s) performed to the primary site.For further information see FORDS page 135.</td></tr><tr><td>.041</td><td>surgery of primary site date</td><td>0;11</td><td>DATE-TIME</td><td></td><td></td><td>Records the date of the most definitive surgical resection of theprimary site performed as part of subsequent treatment.</td></tr><tr><td>.05</td><td>radiation</td><td>0;5</td><td>SET OF CODES</td><td>0:None<br/>1:Beam radiation<br/>2:Radioactive implants<br/>3:Radioisotopes<br/>4:Beam + implants or radioisotopes<br/>5:Radiation, NOS<br/>7:Refused radiation<br/>8:Recommended, unknown if given<br/>9:Unknown if administered<br/></td><td></td><td> Identifies the type of radiation given as part of subsequent treatment.</td></tr><tr><td>.051</td><td>radiation date</td><td>0;12</td><td>DATE-TIME</td><td></td><td></td><td>This is the date on which radiation therapy was given.</td></tr><tr><td>.06</td><td>chemotherapy</td><td>0;6</td><td>SET OF CODES</td><td>00:None<br/>01:Chemotherapy, NOS<br/>02:Single agent<br/>03:Multiagent<br/>82:Not admin/contraindicated<br/>85:Pt died prior to tx<br/>86:Not admin, no reason given<br/>87:Refused by pt<br/>88:Unknown if admin<br/>99:Unknown, death cert<br/></td><td></td><td>Records the type of chemotherapy administered as subsequenttreatment at this and at all other facilities.  If chemotherapywas not administered, then this item records the reason it was notadministered to the patient.  Chemotherapy consists of a group ofanticancer drugs that inhibit the reproduction of cancer cells byinterfering with DNA synthesis and mitosis.For further information see FORDS pages 171-172.</td></tr><tr><td>.061</td><td>chemotherapy date</td><td>0;13</td><td>DATE-TIME</td><td></td><td></td><td>This is the date on which chemotherapy was initiated.</td></tr><tr><td>.07</td><td>hormone therapy</td><td>0;7</td><td>SET OF CODES</td><td>00:None<br/>01:Hormone therapy<br/>82:Not admin/contraindicated<br/>85:Pt died prior to tx<br/>86:Not admin, no reason given<br/>87:Refused by pt<br/>88:Unknown if admin<br/>99:Unknown, death cert<br/></td><td></td><td>Records the type of hormone therapy administered as subsequenttreatment at this and all other facilities.  If hormone therapywas not administered, then this item records the reason it wasnot administered to the patient.  Hormone therapy consists of agroup of drugs that may affect the long-term control of a cancer'sgrowth.  It is not usually used as a curative measure.For further information see FORDS pages 175-176.</td></tr><tr><td>.071</td><td>hormone therapy date</td><td>0;14</td><td>DATE-TIME</td><td></td><td></td><td>This is the date on which hormone/steroid therapy was initiated.</td></tr><tr><td>.08</td><td>immunotherapy</td><td>0;8</td><td>SET OF CODES</td><td>00:None<br/>01:Immunotherapy<br/>82:Not admin/contraindicated<br/>85:Pt died prior to tx<br/>86:Not admin, no reason given<br/>87:Refused by pt<br/>88:Unknown if admin<br/>99:Unknown, death cert</td><td></td><td>Records the type of immunotherapy administered as subsequenttreatment at this and all other facilities.  If immunotherapywas not administered, then this item records the reason it wasnot administered to the patient.  Immunotherapy consists ofbiological or chemical agents that alter the immune system orchange the host's response to the tumor cells.For further information see FORDS pages 179-180.</td></tr><tr><td>.081</td><td>immunotherapy date</td><td>0;15</td><td>DATE-TIME</td><td></td><td></td><td>The date immunotherapy was started.</td></tr><tr><td>.09</td><td>other treatment</td><td>0;9</td><td>SET OF CODES</td><td>0:None<br/>1:Other<br/>2:Other - Experimental<br/>3:Other - Double Blind<br/>6:Other - Unproven<br/>7:Refusal<br/>8:Reccommended, unknown if administered<br/>9:Unknown<br/></td><td></td><td>Identifies other treatment that cannot be defined as surgery, radiation,or systemic therapy.For further informatin see FORDS page 186. </td></tr><tr><td>.091</td><td>other treatment start date</td><td>0;16</td><td>DATE-TIME</td><td></td><td></td><td>Records the date on which other treatment began at any facility.For further information see FORDS pages 184-185.</td></tr><tr><td>1</td><td>radiation sequence</td><td>0;2</td><td>SET OF CODES</td><td>0:Not Applicable<br/>2:Radiation Before Surgery<br/>3:Radiation After Surgery<br/>4:Both Before AND After Surgery<br/>5:Intraoperative Radiation<br/>6:Intraoperative Radiation with other radiation before/after surgery<br/>9:Sequence Unknown<br/></td><td></td><td>This is the sequence of beam radiation therapy performed.</td></tr><tr><td>2</td><td>place</td><td>0;3</td><td>POINTER</td><td><a href="160_19.html">160.19</a></td><td></td><td>This is the institution performing the treatment.</td></tr><tr><td>3</td><td>subsequent therapy comments</td><td>1;0</td><td>WORD-PROCESSING</td><td></td><td></td><td>This is a multi-line free text field permitting comments to be entered.</td></tr><tr><td>4</td><td>interstitial radiation</td><td>2;1</td><td>SET OF CODES</td><td>1:Yes<br/>2:No, not recommended<br/>3:Patient refused interstitial radiation<br/>4:Radiation planned, but not given<br/>9:Unknown<br/></td><td></td><td>Record whether the patient received interstitial radiation.</td></tr><tr><td>5</td><td>iodine 125</td><td>2;2</td><td>SET OF CODES</td><td>1:Yes<br/>2:No<br/>9:Unknown<br/></td><td></td><td>Record whether Iodine 125 was used interstitially.</td></tr><tr><td>6</td><td>gold 198</td><td>2;3</td><td>SET OF CODES</td><td>1:Yes<br/>2:No<br/>9:Unknown<br/></td><td></td><td>Record whether Gold 198 was used interstitially.</td></tr><tr><td>7</td><td>palladium 103</td><td>2;4</td><td>SET OF CODES</td><td>1:Yes<br/>2:No<br/>9:Unknown<br/></td><td></td><td>Record whether Palladium 103 was used interstitially.</td></tr><tr><td>8</td><td>iridium 192</td><td>2;5</td><td>SET OF CODES</td><td>1:Yes<br/>2:No<br/>9:Unknown<br/></td><td></td><td>Record whether Iridium 192 was used interstitially.</td></tr><tr><td>9</td><td>other interstitial, nos</td><td>2;6</td><td>SET OF CODES</td><td>1:Yes<br/>2:No<br/>9:Unknown<br/></td><td></td><td>Record whether other isotopes were used interstitially.</td></tr><tr><td>10</td><td>external radiation</td><td>2;7</td><td>SET OF CODES</td><td>1:Yes<br/>2:No, not recommended<br/>3:Patient refused external radiation<br/>4:Radiation planned, but not given<br/>9:Unknown<br/></td><td></td><td>Record whether the patient received external radiation.</td></tr><tr><td>11</td><td>prostate region only</td><td>2;8</td><td>SET OF CODES</td><td>1:Yes<br/>2:No<br/>9:Unknown<br/></td><td></td><td>Record whether the prostate region only was irradiated.</td></tr><tr><td>12</td><td>prostate and pelvic nodes</td><td>2;9</td><td>SET OF CODES</td><td>1:Yes<br/>2:No<br/>9:Unknown<br/></td><td></td><td>Record whether the prostate and pelvic nodes were irradiated.</td></tr><tr><td>13</td><td>prostate & pelvic para-aortic</td><td>2;10</td><td>SET OF CODES</td><td>1:Yes<br/>2:No<br/>9:Unknown<br/></td><td></td><td>Record whether the prostate and pelvic para-aortic nodes were irradiated.</td></tr><tr><td>14</td><td>distant metastatic sites</td><td>2;11</td><td>SET OF CODES</td><td>1:Yes<br/>2:No<br/>9:Unknown<br/></td><td></td><td>Record whether distant metastatic sites were irradiated.</td></tr><tr><td>15</td><td>other external sites, nos</td><td>2;12</td><td>SET OF CODES</td><td>1:Yes<br/>2:No<br/>9:Unknown<br/></td><td></td><td>Record whether other external sites were irradiated.</td></tr><tr><td>16</td><td>radiation planned/given</td><td>2;13</td><td>SET OF CODES</td><td>1:Yes<br/>2:No, not recommended<br/>3:Patient refused radiation therapy<br/>4:Radiation planned, but not given<br/>9:Unknown<br/></td><td></td><td>Record whether the patient received subsequent radiation therapy.</td></tr><tr><td>17</td><td>total rad dose (prostate)</td><td>2;14</td><td>SET OF CODES</td><td>1:Less than 1999 rad<br/>2:2000-3000 rad<br/>3:3001-4000 rad<br/>4:4001-5000 rad<br/>5:5001-6000 rad<br/>6:6001-7000 rad<br/>7:More than 7001 rad<br/>8:Not given<br/>9:Rad dose unknown<br/></td><td></td><td>Record the total (external) rad dose given to the prostate; this includesboost dosage.  Do not include interstitial rad dose.  If it is known thatthe patient received radiation therapy, but the amount given is unknown,code 9 (rad dose unknown).</td></tr><tr><td>18</td><td>total rad dose (pelvic nodes)</td><td>2;15</td><td>SET OF CODES</td><td>1:Less than 1999 rad<br/>2:2000-3000 rad<br/>3:3001-4000 rad<br/>4:4001-5000 rad<br/>5:5001-6000 rad<br/>8:Not given<br/>9:Rad dose unknown<br/></td><td></td><td>Record the total (external) rad dose given to the pelvic nodes; thisincludes boost dosage.  Do not include interstitial rad dose.  If itis known that the patient received radiation therapy, but the amountgiven is unknown, code 9 (rad dose unknown).</td></tr><tr><td>19</td><td>total rad dose (para-aortic)</td><td>2;16</td><td>SET OF CODES</td><td>1:Less than 1999 rad<br/>2:2000-3000 rad<br/>3:3001-4000 rad<br/>4:4001-5000 rad<br/>5:5001-6000 rad<br/>8:Not given<br/>9:Rad dose unknown<br/></td><td></td><td>Record the total (external) rad dose given to the para-aortic nodes; thisincludes boost dosage.  Do not include interstitial rad dose.  If it isknown that the patient received radiation therapy, but the amount givenis unknown, code 9 (rad dose unknown).</td></tr><tr><td>20</td><td>chemotherapy planned/given</td><td>2;17</td><td>SET OF CODES</td><td>1:Yes<br/>2:No, not recommended<br/>3:Patient refused chemotherapy<br/>4:Chemotherapy planned, but not given<br/>9:Unknown<br/></td><td></td><td>Record whether the patient received chemotherapy.</td></tr><tr><td>21</td><td>adriamycin</td><td>2;18</td><td>SET OF CODES</td><td>1:Yes<br/>2:No<br/>9:Unknown<br/></td><td></td><td>Record whether Adriamycin was administered.</td></tr><tr><td>22</td><td>cytoxan</td><td>2;19</td><td>SET OF CODES</td><td>1:Yes<br/>2:No<br/>9:Unknown<br/></td><td></td><td>Record whether Cytoxan was administered.</td></tr><tr><td>23</td><td>methotrexate</td><td>2;20</td><td>SET OF CODES</td><td>1:Yes<br/>2:No<br/>9:Unknown<br/></td><td></td><td>Record whether Methotrexate was administered.</td></tr><tr><td>24</td><td>5-fluorouracil</td><td>2;21</td><td>SET OF CODES</td><td>1:Yes<br/>2:No<br/>9:Unknown<br/></td><td></td><td>Record whether 5-Fluorourcil was administered.</td></tr><tr><td>25</td><td>other</td><td>2;22</td><td>SET OF CODES</td><td>1:Yes<br/>2:No<br/>9:Unknown<br/></td><td></td><td>Record whether other chemotherapy drugs were administered.</td></tr><tr><td>26</td><td>hormone therapy planned/given</td><td>2;23</td><td>SET OF CODES</td><td>1:Yes<br/>2:No, not recommended<br/>3:Patient refused hormone therapy<br/>4:Hormone therapy planned, but not given<br/>9:Unknown<br/></td><td></td><td>Record whether the patient received hormonal therapy.</td></tr><tr><td>27</td><td>estrogens</td><td>2;24</td><td>SET OF CODES</td><td>1:Yes<br/>2:No<br/>9:Unknown<br/></td><td></td><td>Record whether estrogens were administered.  Code 2 (no) if estrogens werenot given.  Estrogens include diethylstilbestrol (DES), Stilphostrol, TACE(chlorotrianisene), and Emcyt (estramustine phosphate).</td></tr><tr><td>28</td><td>antiandrogens</td><td>2;25</td><td>SET OF CODES</td><td>1:Yes<br/>2:No<br/>9:Unknown<br/></td><td></td><td>Record whether antiandrogens were administered.  Code 2 (no) ifantiandrogens were not given.  The most widely used antiandrogenis Eulexin (fultamide).</td></tr><tr><td>29</td><td>progestational agents</td><td>2;26</td><td>SET OF CODES</td><td>1:Yes<br/>2:No<br/>9:Unknown<br/></td><td></td><td>Record whether progestational agents were administered.  Code 2 (no) ifprogestational agents were not given.  Progestational agents includeProvera (medroxyprogesterone) and Megace (megestrol acetate).</td></tr><tr><td>30</td><td>luteinizing hormone-releasing</td><td>2;27</td><td>SET OF CODES</td><td>1:Yes<br/>2:No<br/>9:Unknown<br/></td><td></td><td>Record whether luteinizing hormone-releasing hormones were administered.Code 2 (no) if luteinizing hormone-releasing hormones were not given.Luteinizing hormone-releasing hormones (LH/RH) include Lupron (leuprolide)and Zoladex (goserelin).</td></tr><tr><td>31</td><td>orchiectomy</td><td>2;28</td><td>SET OF CODES</td><td>1:Yes<br/>2:No<br/>9:Unknown<br/></td><td></td><td>Record whether an orchiectomy was administered.  Code 2 (no) if anorchiectomy was not given.</td></tr><tr><td>32</td><td>other hormones</td><td>2;29</td><td>SET OF CODES</td><td>1:Yes<br/>2:No<br/>9:Unknown<br/></td><td></td><td>Record whether other hormones were administered.  Code 2 (no) if no otherhormones were given.</td></tr><tr><td>33</td><td>recon/restore - delayed</td><td>2;30</td><td>NUMERIC</td><td></td><td></td><td>"Reconstruction/Restoration - Delayed" describes surgical proceduresthat improve the shape and appearance or function of body structuresthat are missing, defective, damaged, or misshapen by cancer orcancer-directed therapies.  "Reconstruction/Restoration - Delayed"is limited to procedures started after the first course of cancer-directed therapy is complete or when it is unknown whether reconstructionwas started during first or second course of therapy.</td></tr><tr><td>34</td><td>recon/restore - delayed date</td><td>2;31</td><td>DATE-TIME</td><td></td><td></td><td></td></tr><tr><td>35</td><td>scope of lymph node surgery</td><td>2;32</td><td>SET OF CODES</td><td>0:None<br/>1:Bx/aspiration, NOS<br/>2:Sentinel Bx<br/>3:Nodes removed, number unk<br/>4:1-3 nodes removed<br/>5:4 or more nodes removed<br/>6:Sentinel + 3, 4 or 5, timing not stated<br/>7:Sentinel + 3, 4, or 5, diff times<br/>9:Unknown/NA<br/></td><td></td><td>Indentifies the removal, biopsy, or aspiration of regionallymph node(s) at the time of surgery of the primary siteor during a separate surgical event.For further information see FORDS pages 138-139.</td></tr><tr><td>36</td><td>surgical proc/other site</td><td>2;33</td><td>SET OF CODES</td><td>0:None<br/>1:Nonprimary surgical proc<br/>2:Nonprimary surgical proc/other regional sites<br/>3:Nonprimary surgical proc/distant lymph node(s)<br/>4:Nonprimary surgical proc/distant site<br/>5:Combination of codes<br/>9:Unknown<br/></td><td></td><td>Records the surgical removal of distant lymph nodesor other issue(s)/organ(s) beyond the primary site.For further information see FORDS page 142.</td></tr><tr><td>37</td><td>number of nodes removed</td><td>2;34</td><td>NUMERIC</td><td></td><td></td><td>Enter the number of regional lymph nodes removed.      00 for No nodes removed      01 for 1 node removed      02 for 2 nodes removed      ...      90 for 90 or more nodes removed      95 for No nodes removed, aspiration performed      96 for Node removal as a sampling, number unknown      97 for Node removal as dissection, number unknown      98 for Nodes surgically removed, number unknown      99 for Unknown; not stated; death certificate only</td></tr><tr><td>38</td><td>scope of ln surgery date</td><td>2;35</td><td>DATE-TIME</td><td></td><td></td><td>This field records the date of the SCOPE OF LYMPH NODE SURGERY (#35)sub-field for this subsequent course of treatment.  The date entered mustbe after or equal to the DATE DX (#3) field.</td></tr><tr><td>39</td><td>surgical proc/other site date</td><td>2;36</td><td>DATE-TIME</td><td></td><td></td><td>This field records the date of the SURGICAL PROC/OTHER SITE (#36)sub-field for this subsequent course of therapy.  The date entered mustbe after or equal to the DATE DX (#3) field.</td></tr><tr><td>40</td><td>mets site resected</td><td>2;37</td><td>SET OF CODES</td><td>0:None<br/>1:Peritoneum<br/>2:Lung<br/>3:Pleura<br/>4:Liver<br/>5:Bone<br/>6:Brain<br/>7:Skin<br/>8:Distant LNS<br/>9:Other<br/></td><td></td><td>This is the Metastatic Site Resected for this subsequent treatment.</td></tr><tr><td>41</td><td>mets site resected date</td><td>2;38</td><td>DATE-TIME</td><td></td><td></td><td>This is the date the Metastatic Site was resected.  The Date must be afteror equal to the DATE DX (#3) field.</td></tr><tr><td>42</td><td>palliative care</td><td>2;39</td><td>SET OF CODES</td><td>0:No palliative care<br/>1:Surgery<br/>2:Radiation<br/>3:Systemic tx<br/>4:Pain management<br/>5:Surg, rad, and/or systemic tx w/o pain mgt<br/>6:Surg, rad, and/or systemic tx w pain mgt<br/>7:Palliative care, type unknown<br/>9:Unknown, not stated<br/></td><td></td><td>Identifies any care provided in an effort to palliate or alleviatesymptoms.  Palliative care is performed to relieve symptoms and mayinclude surgery, radiation therapy, systemic therapy (chemotherapy,hormone therapy or other systemic drugs), and/or pain management therapy.</td></tr></tbody></table></dd></dl></div></div><hr><div class="fmqlResults"><div class='error'><p>Error: Invalid Global File Type: 165.51</p></div></div>
</div>
<div id="footer"><a href="http://www.caregraf.info">Master FileMan's Data</a>&trade; (c) 2017 <span id="flogo"><a href="http://www.caregraf.info">Caregraf</a></span></div>
</body>
</html>
